ShengDa Biological Pharmaceutical Achieves H1 2025 Net Profits of RMB 37.80 Million, Surging by 129.20% Year-on-Year
Continue reading with Effamall membership.
Already a member? Login here.
Tag:
Copy Link
<Prev
Next>
<Prev
Next>
